OPTION CARE HEALTH Announces $3.6 Billion All-Stock Acquisition of Amedisys, OPCH Shares Soar
May 20, 2023
Trending News ☀️
Option Care Health ($NASDAQ:OPCH) (OPCH) is a leading provider of home and alternate site infusion services in the United States. The company offers a full range of home and alternate site infusion services including a broad range of clinical services, such as IVIG, SCIG, home care pharmacy services and nutritional support. OPCH recently announced an all-stock deal to acquire Amedisys, Inc. for a total of $3.6 billion, marking a major milestone for the company and its shareholders. The acquisition will allow OPCH to expand its offerings in home infusion services, post-acute care, hospice, and adult day health care, offering better quality care for their patients. This strategic move has already had a positive effect on OPCH shares, with the company’s stock soaring after the announcement.
The acquisition will broaden OPCH’s portfolio of services and geographic footprint in the healthcare industry, while providing greater access to advanced therapy options for patients. The acquisition of Amedisys will bring a wealth of new resources to OPCH, making them an even stronger provider of home and alternate site infusion services. With this acquisition in place, OPCH is now well-positioned to continue its growth trajectory as it works to meet the needs of more patients.
Price History
On Monday, OPTION CARE HEALTH (OPCH) announced that they would be acquiring Amedisys for $3.6 billion, in an all-stock deal. Upon announcement of the acquisition, OPCH stock opened at $27.0 and closed at $26.8, down by 0.5% from prior closing price of 27.0. The acquisition is expected to expand OPCH’s reach beyond home infusion services, to include hospice and home health services, providing more comprehensive care for the chronically ill and elderly patients it serves. The combined entity will operate under the OPCH name and will be headquartered in Deerfield, Illinois.
The current CEO of OPCH, John Rademacher, will remain in his position, while Amedisys CEO Paul Kusserow, will join the board of directors. The acquisition has been met with enthusiasm from investors, as OPCH shares have soared in response. This growth is expected to continue as the combined entity gains momentum in the marketplace. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for OPCH. More…
| Total Revenues | Net Income | Net Margin |
| 4.04k | 159.49 | 3.9% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for OPCH. More…
| Operations | Investing | Financing |
| 324.62 | -108.45 | -63.99 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for OPCH. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 3.13k | 1.78k | 7.71 |
Key Ratios Snapshot
Some of the financial key ratios for OPCH are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 16.8% | 344.9% | 6.8% |
| FCF Margin | ROE | ROA |
| 7.1% | 12.4% | 5.5% |
Analysis
At GoodWhale, we specialize in evaluating the wellbeing of OPTION CARE HEALTH. After performing a thorough analysis, we’ve determined that OPTION CARE HEALTH is a high risk investment in terms of financial and business aspects, based on our Risk Rating system. We’ve also detected 1 risk warnings in the balance sheet that all potential investors should be aware of. To gain access to this information, simply become a registered user of our platform. With this knowledge, you’ll be able to make an informed decision about investing in OPTION CARE HEALTH with confidence. More…
Peers
The company’s competitors include LHC Group Inc, Singapore Paincare Holdings Ltd, and New York Health Care Inc.
– LHC Group Inc ($NASDAQ:LHCG)
LHC Group Inc is a healthcare provider that offers a wide range of services to its patients. Its services include home health, hospice, community care, and other services. The company has a market cap of 5.14B as of 2022 and a return on equity of 5.37%. The company’s main focus is on providing quality care to its patients and their families.
– Singapore Paincare Holdings Ltd ($SGX:FRQ)
Singapore Paincare Holdings Ltd has a market cap of 36.82M as of 2022. The company’s Return on Equity for the same year is 13.23%.
Singapore Paincare Holdings Ltd is a healthcare company that focuses on the provision of pain management solutions. The company offers a wide range of services including pain consultation, pain relief treatments, and rehabilitation programs. Singapore Paincare Holdings Ltd also provides education and training on pain management for both healthcare professionals and the general public.
– New York Health Care Inc ($OTCPK:BBAL)
New York Health Care Inc is a healthcare company with a market cap of 335.37k as of 2022. It has a Return on Equity of 21.67%. The company provides healthcare services to patients in the New York area.
Summary
Option Care Health, a leading independent provider of home and alternate site infusion services, has announced its agreement to acquire Amedisys Inc. in an all-stock transaction worth $3.6 billion. The combined company seeks to better serve patients with chronic and acute conditions, allowing them to receive care more conveniently in their homes and alternate care sites. The deal is seen as a positive for both companies as it will create a national leader in home infusion services, with a broader range of services and products and increased access to care. Investors should consider the potential upside of the combined company’s size, brand recognition, and financial standing, as well as the risk associated with large mergers.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
